Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

CNS Medication Trials

Ann Arbor, Michigan

CNS medication trials in Ann Arbor, MI

28 CNS medication studies are recruiting participants at sites in Ann Arbor as of November 17, 2026, according to ClinicalTrials.gov. CNS Medication Trials can help you understand your options and connect with a study team.

Call (888) 927-5768
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Ann Arbor at a glance

Depression studies recruiting in Ann Arbor

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

    • Phase 2
    • Ages 18 to 80
    • All sexes
    Sponsor
    Reunion Neuroscience Inc
    Study site
    University of Michigan
    Registry record
    NCT07002034 · updated
  2. ALTO-207 in Adults With Treatment-resistant Depression (TRD)

    • Phase 2
    • Ages 18 to 75
    • All sexes
    Sponsor
    Alto Neuroscience
    Registry record
    NCT07553637 · updated
  3. ALTO-100 in Bipolar Disorder With Depression (BD-D)

    • Phase 2
    • Ages 18 to 70
    • All sexes
    Sponsor
    Alto Neuroscience
    Registry record
    NCT06656416 · updated
  4. Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid Depression

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    VA Office of Research and Development
    Study site
    VA Ann Arbor Healthcare System, Ann Arbor, MI
    Registry record
    NCT06419439 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Ann Arbor, MI on ClinicalTrials.gov.

Schizophrenia studies recruiting in Ann Arbor

  1. A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

    • Phase 2
    • Ages 18 to 65
    • All sexes
    Sponsor
    MapLight Therapeutics
    Registry record
    NCT07459647 · updated

Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Ann Arbor, MI on ClinicalTrials.gov.

Bipolar disorder studies recruiting in Ann Arbor

  1. Correcting Circadian Rhythms to Breakthrough in Bipolar Disorder

    • Phase 2
    • Ages 18 to 60
    • All sexes
    Sponsor
    Leslie Swanson
    Study site
    University of Michigan
    Registry record
    NCT06226025 · updated

Source: ClinicalTrials.gov. Data processed . See every bipolar disorder study recruiting in Ann Arbor, MI on ClinicalTrials.gov.

Parkinson's disease studies recruiting in Ann Arbor

  1. DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

    • Phase 3
    • Ages 18 and older
    • Female participants
    Sponsor
    AstraZeneca
    Registry record
    NCT06989112 · updated
  2. Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments

    • Phase 1/2
    • Ages 45 and older
    • All sexes
    Sponsor
    Prabesh Kanel
    Study site
    Domino's Farms
    Registry record
    NCT07154511 · updated
  3. Tributyrin for Progressive Supranuclear Palsy (PSP): Virtual Trial

    • Phase 1/2
    • Ages 45 and older
    • All sexes
    Sponsor
    Prabesh Kanel
    Study site
    Domino's Farms
    Registry record
    NCT07863180 · updated
  4. A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations

    • Phase 2
    • Ages 30 to 80
    • All sexes
    Sponsor
    Appello Pharmaceuticals, Inc.
    Study site
    University of Michigan Health System (UMHS) (Site #202)
    Registry record
    NCT07432958 · updated
  5. Reducing Falls With Varenicline in Hypocholinergic Parkinson Disease

    • Phase 2
    • Ages 45 and older
    • All sexes
    Sponsor
    Vikas Kotagal
    Study site
    University of Michigan
    Registry record
    NCT06679374 · updated

Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Ann Arbor, MI on ClinicalTrials.gov.

Multiple sclerosis (MS) studies recruiting in Ann Arbor

  1. A Study of AZD0120 in Autoimmune Diseases

    • Phase 1/2
    • Ages 18 to 75
    • All sexes
    Sponsor
    AstraZeneca
    Registry record
    NCT07295847 · updated
  2. A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    TG Therapeutics, Inc.
    Study site
    TG Therapeutics Investigational Trial Site
    Registry record
    NCT06680037 · updated
  3. Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype

    • Phase 2
    • Ages 18 to 65
    • All sexes
    Sponsor
    Tiffany J. Braley, MD, MS
    Study site
    University of Michigan
    Registry record
    NCT05269628 · updated

Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Ann Arbor, MI on ClinicalTrials.gov.

Epilepsy studies recruiting in Ann Arbor

  1. A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

    • Phase 3
    • Ages 12 and older
    • All sexes
    Sponsor
    Xenon Pharmaceuticals Inc.
    Study site
    University of Michigan Hospitals
    Registry record
    NCT05667142 · updated
  2. ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome

    • Phase 1/2
    • Ages 2 to 12
    • All sexes
    Sponsor
    Ionis Pharmaceuticals, Inc.
    Study site
    University of Michigan Health System
    Registry record
    NCT07531745 · updated
  3. A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome

    • Phase 1/2
    • From 6 months, up to 17 years
    • All sexes
    Sponsor
    Encoded Therapeutics
    Study site
    Mott Children's Hospital
    Registry record
    NCT05419492 · updated
  4. Outcomes After Planned Discontinuation of AntiSeizure Medication

    • Phase 4
    • Ages 18 and older
    • All sexes
    Sponsor
    University of Michigan
    Study site
    University of Michigan
    Registry record
    NCT07750496 · updated

Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Ann Arbor, MI on ClinicalTrials.gov.

Migraine studies recruiting in Ann Arbor

  1. Study of EVO756 in Adults With Migraine

    • Phase 2
    • Ages 18 to 64
    • All sexes
    Sponsor
    Evommune, Inc.
    Study site
    Michigan Headache and Neurological Institute
    Registry record
    NCT07616128 · updated
  2. A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    TriGemX Bio, Inc.
    Study site
    Michigan Headache Pain & Neurological Institute
    Registry record
    NCT07645924 · updated
  3. A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    TriGemX Bio, Inc.
    Study site
    Michigan Headache Pain & Neurological Institute
    Registry record
    NCT07674654 · updated
  4. Randomized Study in Children and Adolescents With Migraine: Acute Treatment

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    Pfizer
    Study site
    Michigan Head Pain & Neurological Institute
    Registry record
    NCT04649242 · updated
  5. Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    Pfizer
    Study site
    Michigan Head Pain and Neurological Institute
    Registry record
    NCT04743141 · updated
  6. A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine

    • Phase 4
    • Ages 18 and older
    • All sexes
    Sponsor
    Pfizer
    Study site
    Michigan Headache & Neurological Institute
    Registry record
    NCT07609914 · updated
  7. A Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Pfizer
    Study site
    Michigan Headache & Neurological Institute
    Registry record
    NCT07729462 · updated
  8. A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

    • Phase 3
    • Ages 12 to 17
    • All sexes
    Sponsor
    AbbVie
    Study site
    Michigan Headache & Neurological Institute /ID# 270942
    Registry record
    NCT06810505 · updated
  9. A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    AbbVie
    Study site
    Michigan Headache & Neurological Institute (MHNI) /ID# 247468
    Registry record
    NCT05711394 · updated
  10. A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

    • Phase 3
    • Ages 18 to 45
    • Female participants
    Sponsor
    Pfizer
    Study site
    Michigan Headache & Neurological Institute
    Registry record
    NCT06641466 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Ann Arbor, MI on ClinicalTrials.gov.

Ask about studies near Ann Arbor

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a medication, as each study is coded in the registry.

CNS Medication Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5768

or send a short form

How should we reach you?

Call